000 | 01385 a2200373 4500 | ||
---|---|---|---|
005 | 20250516234327.0 | ||
264 | 0 | _c20141121 | |
008 | 201411s 0 0 ger d | ||
022 | _a1439-4413 | ||
024 | 7 |
_a10.1055/s-0034-1370285 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aStarck, M | |
245 | 0 | 0 |
_a[Thrombotic microangiopathies]. _h[electronic resource] |
260 |
_bDeutsche medizinische Wochenschrift (1946) _cOct 2014 |
||
300 |
_a1993-6 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Review | ||
650 | 0 | 4 |
_aAdrenal Cortex Hormones _xtherapeutic use |
650 | 0 | 4 |
_aAntibodies, Monoclonal, Humanized _xtherapeutic use |
650 | 0 | 4 |
_aAntibodies, Monoclonal, Murine-Derived _xtherapeutic use |
650 | 0 | 4 | _aCoombs Test |
650 | 0 | 4 |
_aHemolytic-Uremic Syndrome _xclassification |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aImmunosuppressive Agents _xtherapeutic use |
650 | 0 | 4 | _aPlasma Exchange |
650 | 0 | 4 | _aPredictive Value of Tests |
650 | 0 | 4 | _aPrognosis |
650 | 0 | 4 |
_aPurpura, Thrombotic Thrombocytopenic _xclassification |
650 | 0 | 4 | _aRituximab |
650 | 0 | 4 | _aSurvival Rate |
650 | 0 | 4 |
_aThrombotic Microangiopathies _xclassification |
700 | 1 | _aWendtner, C-M | |
773 | 0 |
_tDeutsche medizinische Wochenschrift (1946) _gvol. 139 _gno. 40 _gp. 1993-6 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1055/s-0034-1370285 _zAvailable from publisher's website |
999 |
_c24221171 _d24221171 |